Prostate biopsy in Connecticut: the highest-volume physicians
34 physicians in Connecticut billed Medicare for 868 prostate biopsy procedures in 2024. The top 26, with the year before beside it.
Top 26
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | Ralph J. Devito, MDUrology · New Haven | 95 | 90 | +6% |
| 2 | Joseph M. Brito, MDUrology · New Haven | 57 | 37 | +54% |
| 3 | Michael E. Karellas, MDUrology · New Haven | 47 | 25 | +88% |
| 3 | Preston C. Sprenkle, MDUrology · New Haven | 47 | 39 | +21% |
| 5 | Douglas G. Ridyard, MDUrology · Farmington | 38 | 34 | +12% |
| 6 | York P. Moy, MDUrology · Middlebury | 36 | 39 | −8% |
| 7 | Michael S. Leapman, MDUrology · New Haven | 35 | 25 | +40% |
| 8 | John W. Colberg, MDUrology · New Haven | 33 | 37 | −11% |
| 8 | Gerard Pregenzer, MDUrology · Enfield | 33 | 21 | +57% |
| 10 | Jonathan E. Bernie, MDUrology · Norwalk | 29 | 45 | −36% |
| 11 | Christian E. Bartels, MDUrology · Farmington | 28 | — | |
| 12 | James F. Devanney, MDUrology · Torrington | 27 | 11 | |
| 13 | Brian L. Sperling, DOUrology · Shelton | 26 | 23 | +13% |
| 13 | Stuart S. Kesler, MDUrology · Hartford | 26 | 12 | |
| 15 | Johnny A. Chang, MDUrology · Torrington | 25 | 21 | +19% |
| 16 | John J. Bruno, MDUrology · Danbury | 23 | 16 | |
| 16 | Guy J. Manetti, MDUrology · New Haven | 23 | 31 | −26% |
| 18 | Richard O. Frink, MDUrology · Middletown | 19 | 17 | |
| 19 | Stanford R. Broder, MDUrology · Danbury | 18 | 17 | |
| 20 | Nicholas Stroumbakis, MDUrology · Greenwich | 17 | 30 | −43% |
| 21 | G T. Trono, MDUrology · Hartford | 16 | 18 | |
| 22 | Michael E. Goltzman, MDUrology · Danbury | 15 | 16 | |
| 22 | Edward G. Myer, MDUrology · Middletown | 15 | — | |
| 24 | Hugh J. Lavery, MDUrology · Stamford | 14 | — | |
| 24 | Eric G. Katz, MDUrology · Hartford | 14 | 12 | |
| 24 | Adam E. Ludvigson, MDUrology · New Haven | 14 | — |
A rank counts procedures billed under the physician's own NPI (CPT 55700), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.